Pfizer Inc


Pfizer Inc.

Related content

News |

Pfizer says tweaked COVID-19 shots boost omicron protection

Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators...

News |

CDC recommends COVID-19 vaccines for children under 5

NEW YORK (AP) — U.S. health officials on Saturday recommended COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the...

News |

FDA authorizes 1st COVID-19 shots for infants, preschoolers

U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week.

News |

US: Pfizer COVID-19 shot appears effective for kids under 5

WASHINGTON (AP) — Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids...

News |

Marathon US hearings to decide fate of COVID shots for tots

Parents anxious to finally vaccinate their youngest children against COVID-19, strap in: A lot is set to happen over the next week.

News |

FDA advisers back Novavax COVID shots as 4th US option

American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on...

Latest Analysis |

Is Pfizer a Good Investment?

Pfizer offers a lot more to shareholders than a boost from COVID-19 vaccine revenues. With growth potential ahead, it may be undervalued.

Latest Analysis |

Is Pfizer Stock a Buy as COVID Pills Gear Up for Approval?

Pfizer's COVID-19 pill, vaccine and CFO resignation are making headlines this week. Does the news help boost its investment thesis?

Sign up for VTM Updates

Form submitted successfully!

Top Picks for Q2 2022

View More

Crypto Corner

Learn your NFTs from your BTCs